Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Aug 10;95(10):1148–1157. doi: 10.1002/ajh.25918

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 The Authors. American Journal of Hematology published by Wiley Periodicals LLC.

This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

PMC Copyright notice

Relapse‐free survival (RFS) and cumulative incidence of relapse (CIR) in AML patients receiving intensive chemotherapy according to MRD status. A, RFS of AML patients according to MRD status (n = 39). Patients with a positive MRD status as measured by our two‐step MRD assay had a significantly shorter duration of RFS (P = .0031). B, Competing risk analysis for CIR in AML patients according to their MRD status. C, Box plot displaying univariate analysis of hazard ratios of risk factors for CIR. D, Box plot displaying multivariate analysis of hazard ratios of risk factors for CIR. alloSCT, allogeneic stem cell transplantation; MRD pos, measureable residual disease positive; ELN int/adverse, European Leukemia Net intermediate/adverse risk [Color figure can be viewed at wileyonlinelibrary.com]